Data sources
| Data set . | Sample number . | Cell types . | Reference . |
|---|---|---|---|
| Normal blood and BM populations | |||
| GSE42519 | 34 | HSC, MPP, CMP, MEP, GMP, early PM, late PM, MY, MM, BC, PMN | This study |
| GSE17054 | 2 | HSC | Majeti et al19 |
| GSE19599 | 4 | GMP, MEP | Andersson et al20 |
| GSE11864 | 2 | Monocytes | Hu et al21 |
| E-MEXP-1242 | 2 | Monocytes | Wildenberg et al22 |
| Total | 44 | ||
| AML patient samples | |||
| GSE13159 | 191 | t(8;21), inv(16), t(15;17), t(11q23), complex | Haferlach et al9 |
| GSE14468 | 526 | MDS:-5/7(q), −9q, 11q23, 8, complex; AML: NK, complex, inv(3q), inv(16), t(15;17), t(6;9), t(8;21), t(9;22) | Wouters et al11 |
| GSE15434 | 251 | NK-AML | Kohlmann et al,2 Klein et al12 |
| TCGA | 183 | Various genetic aberrations, including t(8;21), inv(16), t(15;17), t(11q23), complex | Cancer Genome Atlas Research Network13 |
| GSE6891 | 91 | Various genetic aberrations, including t(8;21), inv(16), t(15;17), t(11q23) | de Jonge et al18 |
| GSE12417 | 79 | NK-AML | Metzeler et al15 |
| Total | 1321 | ||
| Data set . | Sample number . | Cell types . | Reference . |
|---|---|---|---|
| Normal blood and BM populations | |||
| GSE42519 | 34 | HSC, MPP, CMP, MEP, GMP, early PM, late PM, MY, MM, BC, PMN | This study |
| GSE17054 | 2 | HSC | Majeti et al19 |
| GSE19599 | 4 | GMP, MEP | Andersson et al20 |
| GSE11864 | 2 | Monocytes | Hu et al21 |
| E-MEXP-1242 | 2 | Monocytes | Wildenberg et al22 |
| Total | 44 | ||
| AML patient samples | |||
| GSE13159 | 191 | t(8;21), inv(16), t(15;17), t(11q23), complex | Haferlach et al9 |
| GSE14468 | 526 | MDS:-5/7(q), −9q, 11q23, 8, complex; AML: NK, complex, inv(3q), inv(16), t(15;17), t(6;9), t(8;21), t(9;22) | Wouters et al11 |
| GSE15434 | 251 | NK-AML | Kohlmann et al,2 Klein et al12 |
| TCGA | 183 | Various genetic aberrations, including t(8;21), inv(16), t(15;17), t(11q23), complex | Cancer Genome Atlas Research Network13 |
| GSE6891 | 91 | Various genetic aberrations, including t(8;21), inv(16), t(15;17), t(11q23) | de Jonge et al18 |
| GSE12417 | 79 | NK-AML | Metzeler et al15 |
| Total | 1321 | ||
Description and origin of all microarray data sets used in this study, including normal blood and BM populations and AML patient samples. All samples were run on the HG-U133 Plus 2.0 Array Affymetrix platform.